Announcements Trials
Browse Landscape

Status

Completed 4Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 21Observational 6

Sponsor

Cancer Type

Other hematologic neoplasm 6Myeloid 4

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Philadelphia Chromosome 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Observational × bosutinib × Clear all
NCT06297161 2026-04-14

A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).

Pfizer

Recruiting
600 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07091019 2025-07-29

ASC4REAL-2

Novartis

Not yet recruiting
1,000 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT02501330 2024-04-30

BLF

Pfizer

Completed
702 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05286528 2023-10-27

Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database

Pfizer

Completed
1,484 enrolled 6 charts
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02546375 2023-10-03

A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

Pfizer

Completed
87 enrolled 22 charts
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05363488 2023-04-03

Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland

Pfizer

Completed
17 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Philadelphia Chromosome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡